Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The goal of this research inquiry is to provideinsights into preventive services for lung cancer. This research will contribute to the concurrent progress in lung cancer screening with low dose computed tomography, which has taken place in officialrecommendations and clinical practice in the U.S. in recent years.
PI is Jiang Li, Ph.D., MPH. Co-PIs are Sukyung Chung, Ph.D., Dorothy Hung, Ph.D., M.A., MPH, both with PAMFRI, and Esther Wei, Sc.D., with the California Pacific Medical Center Research Institute.
Principal Investigator
Funder
Tobacco-Related Disease Research Program (University of California)
Related Studies
Cancer Liquid Biopsy Monitoring Study
Investigators: Mohammed Kashani-Sabet, M.D., Deepti Behl, MD
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Cheryl Stults, Ph.D., Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD
Improving Cancer Care
Investigator: Su-Ying Liang, Ph.D.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: Monique de Bruin, M.D., MPH, External PI, Principal Investigator, Su-Ying Liang, Ph.D.
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS
Dana Farber 13-09-259 DCIS Registry
Investigator: Kristie A. Bobolis, M.D.